Krtl Holding Group Inc (KRTL)

$0.10 +0.01 (10.63%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 70,100
Avg Vol 64,328
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 33%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally. It also distributes soy-based food products. The company holds leases on natural springs located in Canada, Florida, and New York. The company was formerly known as Queench, Inc. and changed its name to KRTL Holding Group, Inc in July 2022. KRTL Holding Group, Inc was founded in 1999 and is based in La...

Industry: Conglomerates
Sector: Industrials
Phone: 800 707 0586
Address:
14143 Denver W Parkway, Suite 100, Lakewood, United States
NewsAndFilings
NewsAndFilings Nov. 21 at 3:22 PM
$KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
MsGrumpy
MsGrumpy Nov. 21 at 2:41 PM
$KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
Giants67
Giants67 Nov. 21 at 2:28 PM
$KRTL KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 17 at 3:04 PM
$KRTL HOLDING GROUP INC. REPORTS THIRD QUARTER 2025 RESULTS (UNAUDITED) AND FILES PCAOB-AUDITED 2024 AND 2023 FINANCIAL STATEMENTS https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
MsGrumpy
MsGrumpy Nov. 17 at 3:00 PM
$KRTL KRTL Holding Group Inc. reported current financial results & completed a PCAOB audit on 2023/24. https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
Giants67
Giants67 Nov. 17 at 2:21 PM
$KRTL KRTL Holding Group Inc. (OTC: KRTL) (the “Company”) reported financial results for the three and nine months ended September 30, 2025, and announced the completion of a PCAOB audit of its consolidated financial statements for the years ended December 31, 2024, and 2023. https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 16 at 2:27 PM
Weekly Rundown: $BMTM Time Business News Article $PETV Digital Landia Technical Whitepaper $BLGO Q3 Earning Results $KRTL Investors Presentation $CNRC Q3 Financials $OODH Investor Updates - Expansion
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 8:32 PM
$KRTL The Global Expansion Story Nobody Is Watching KRTL Holding Group is quietly transforming into an international biotech, pharma, and supply-chain force through its two key subsidiaries: KRTL International Corp and KRTL Biotech, Inc. KRTL isn’t just talking global, they’re executing: ▪️ KRTL International is leading major projects across Bolivia and Latin America, including large-scale land development, manufacturing zones, logistics, and cross-border API and botanical sourcing. ▪️ They’re positioning Bolivian-made pharmaceuticals and extracts for U.S. entry under FDA-aligned pathways. ▪️A joint venture with CIQ unlocks access to high-value compounds and raw materials from the Amazon region. ▪️This strategy creates a cost-efficient alternative to China/India which is rare for a micro-cap. 💎 A global manufacturing + biotech distribution + regulatory strategy this advanced is something most small caps never even come close to. Disclaimer: https://fh.bio/jcoop
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 4:41 PM
$KRTL KRTL has quietly become one of 2025’s biggest stealth movers: ripping from $0.01 to the mid-.16s before settling into a clean, textbook bull flag pattern. This consolidation is tight, controlled, and signaling a potential next leg higher. Key Technicals: ▫️Support: $0.075–$0.082, $0.095–$0.10, and $0.1199 ▫️ Pivots: $0.1199, $0.1300, $0.1450 ▫️ Resistance: $0.1450, $0.1550 🚨 Major Breakout Level: $0.1650 (the top of the flag and the level that can trigger a full breakout) Why This Matters KRTL is a nanofloat, conviction is high, and the fundamentals are strengthening with their biotech subsidiary acting as a true catalyst engine. The bull flag shows buyers are in control, absorbing every dip and setting up for momentum. The Breakdown KRTL is bull-flagging, coiling, and getting ready for a possible explosive move. A break over $0.1650 could unleash the next surge and with a float this small, it can move fast. Disclaimer: https://fh.bio/jcoop
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 2:33 PM
$KRTL is quietly transforming from an overlooked OTC micro-cap into a biotech-driven disruptor with massive potential upside. The company’s biotech subsidiary is lining up regulatory wins, global manufacturing access, and API/pharma capabilities that could turn this tiny 9M market-cap sleeper into a full-blown breakout story the moment real revenue or contracts hit. This isn’t the same KRTL from years ago; their biotech arm is the game changer. They’re targeting FDA-registered manufacturing pathways, expanding internationally, and positioning themselves in sectors that can send this nano-cap flying. ⚡ Why This Should Be on Your Radar * Biotech subsidiary = real catalysts * Regulatory + international expansion underway * Micro-cap float + low market cap = tiny spark → massive move With a 52 week range swinging from fractions of a penny to major spikes. Any confirmed regulatory milestone, acquisition completion, or commercial contract can be explosive. Disclaimer: https://fh.bio/jcoop
0 · Reply
Latest News on KRTL
No data available.
NewsAndFilings
NewsAndFilings Nov. 21 at 3:22 PM
$KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
MsGrumpy
MsGrumpy Nov. 21 at 2:41 PM
$KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
Giants67
Giants67 Nov. 21 at 2:28 PM
$KRTL KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Ophthalmic-Pharmaceutical-Capabilities-to-Address-Vision-Care-Needs-in-Emerging-and-Global-Marke?id=501153
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 17 at 3:04 PM
$KRTL HOLDING GROUP INC. REPORTS THIRD QUARTER 2025 RESULTS (UNAUDITED) AND FILES PCAOB-AUDITED 2024 AND 2023 FINANCIAL STATEMENTS https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
MsGrumpy
MsGrumpy Nov. 17 at 3:00 PM
$KRTL KRTL Holding Group Inc. reported current financial results & completed a PCAOB audit on 2023/24. https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
Giants67
Giants67 Nov. 17 at 2:21 PM
$KRTL KRTL Holding Group Inc. (OTC: KRTL) (the “Company”) reported financial results for the three and nine months ended September 30, 2025, and announced the completion of a PCAOB audit of its consolidated financial statements for the years ended December 31, 2024, and 2023. https://www.globenewswire.com/news-release/2025/11/17/3189222/0/en/KRTL-HOLDING-GROUP-INC-REPORTS-THIRD-QUARTER-2025-RESULTS-UNAUDITED-AND-FILES-PCAOB-AUDITED-2024-AND-2023-FINANCIAL-STATEMENTS.html
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 16 at 2:27 PM
Weekly Rundown: $BMTM Time Business News Article $PETV Digital Landia Technical Whitepaper $BLGO Q3 Earning Results $KRTL Investors Presentation $CNRC Q3 Financials $OODH Investor Updates - Expansion
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 8:32 PM
$KRTL The Global Expansion Story Nobody Is Watching KRTL Holding Group is quietly transforming into an international biotech, pharma, and supply-chain force through its two key subsidiaries: KRTL International Corp and KRTL Biotech, Inc. KRTL isn’t just talking global, they’re executing: ▪️ KRTL International is leading major projects across Bolivia and Latin America, including large-scale land development, manufacturing zones, logistics, and cross-border API and botanical sourcing. ▪️ They’re positioning Bolivian-made pharmaceuticals and extracts for U.S. entry under FDA-aligned pathways. ▪️A joint venture with CIQ unlocks access to high-value compounds and raw materials from the Amazon region. ▪️This strategy creates a cost-efficient alternative to China/India which is rare for a micro-cap. 💎 A global manufacturing + biotech distribution + regulatory strategy this advanced is something most small caps never even come close to. Disclaimer: https://fh.bio/jcoop
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 4:41 PM
$KRTL KRTL has quietly become one of 2025’s biggest stealth movers: ripping from $0.01 to the mid-.16s before settling into a clean, textbook bull flag pattern. This consolidation is tight, controlled, and signaling a potential next leg higher. Key Technicals: ▫️Support: $0.075–$0.082, $0.095–$0.10, and $0.1199 ▫️ Pivots: $0.1199, $0.1300, $0.1450 ▫️ Resistance: $0.1450, $0.1550 🚨 Major Breakout Level: $0.1650 (the top of the flag and the level that can trigger a full breakout) Why This Matters KRTL is a nanofloat, conviction is high, and the fundamentals are strengthening with their biotech subsidiary acting as a true catalyst engine. The bull flag shows buyers are in control, absorbing every dip and setting up for momentum. The Breakdown KRTL is bull-flagging, coiling, and getting ready for a possible explosive move. A break over $0.1650 could unleash the next surge and with a float this small, it can move fast. Disclaimer: https://fh.bio/jcoop
0 · Reply
jcooptechit
jcooptechit Nov. 13 at 2:33 PM
$KRTL is quietly transforming from an overlooked OTC micro-cap into a biotech-driven disruptor with massive potential upside. The company’s biotech subsidiary is lining up regulatory wins, global manufacturing access, and API/pharma capabilities that could turn this tiny 9M market-cap sleeper into a full-blown breakout story the moment real revenue or contracts hit. This isn’t the same KRTL from years ago; their biotech arm is the game changer. They’re targeting FDA-registered manufacturing pathways, expanding internationally, and positioning themselves in sectors that can send this nano-cap flying. ⚡ Why This Should Be on Your Radar * Biotech subsidiary = real catalysts * Regulatory + international expansion underway * Micro-cap float + low market cap = tiny spark → massive move With a 52 week range swinging from fractions of a penny to major spikes. Any confirmed regulatory milestone, acquisition completion, or commercial contract can be explosive. Disclaimer: https://fh.bio/jcoop
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 13 at 12:37 PM
Yesterday's Recap: $APRE Q3 Financials $CBDL Secures Major Hemp Flower Order $KRTL Publishes Investor Presentation $KARX and Hockey Canada Partnership
0 · Reply
MsGrumpy
MsGrumpy Nov. 12 at 4:47 PM
$KRTL Holding Group Inc. (published its November 2025 investor presentation. The presentation is available on the company’s website. https://www.krtlholding.com/presentation
0 · Reply
Giants67
Giants67 Nov. 12 at 3:02 PM
$KRTL KRTL Holding Group Inc. (OTCID: KRTL) announced that it has published its November 2025 investor presentation. The presentation is attached to this release and available on the company’s website. https://www.krtlholding.com/presentation
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 12 at 2:59 PM
$KRTL Holding Group Inc. Publishes Investor Presentation https://www.otcmarkets.com/stock/KRTL/news/KRTL-Holding-Group-Inc-Publishes-Investor-Presentation?id=499600
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 7 at 12:48 PM
Yesterday's Recap: $SSII Successful Completion of First Telesurgery $MSCH National Launch of kathy ireland(R) "Laundry Concierge" Program $MMMW a New Hydroelectric Cost Cutting Technology $KRTL Highlights Anti-Allergy and Respiratory Product
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 6 at 5:50 PM
$KRTL Biotech Highlights Anti-Allergy and Respiratory Product Capabilities to Address Global Market Needs https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Anti-Allergy-and-Respiratory-Product-Capabilities-to-Address-Global-Market-Needs?id=498971
0 · Reply
MsGrumpy
MsGrumpy Nov. 6 at 4:20 PM
$KRTL Biotech Highlights Anti-Allergy and Respiratory https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Highlights-Anti-Allergy-and-Respiratory-Product-Capabilities-to-Address-Global-Market-Needs?id=498971
0 · Reply
MsGrumpy
MsGrumpy Nov. 4 at 4:22 PM
$KRTL Holding Group Inc. is proud to spotlight CaviGuard, an innovative dental care system developed in Bolivia and manufactured by its majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp. https://www.otcmarkets.com/stock/KRTL/news/KRTL-Holding-Group-Highlights-Bolivian-Innovation-CaviGuard-Manufactured-by-SIGMA-as-Global-Model-in-Non-Invasive-Dental?id=498549
0 · Reply
NewsAndFilings
NewsAndFilings Nov. 4 at 3:37 PM
$KRTL Holding Group Highlights Bolivian Innovation CaviGuard, Manufactured by SIGMA, as Global Model in Non-Invasive Dental Care https://www.otcmarkets.com/stock/KRTL/news/KRTL-Holding-Group-Highlights-Bolivian-Innovation-CaviGuard-Manufactured-by-SIGMA-as-Global-Model-in-Non-Invasive-Dental?id=498549
0 · Reply
Giants67
Giants67 Nov. 4 at 3:00 PM
$KRTL KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") is proud to spotlight CaviGuard, an innovative dental care system developed in Bolivia and manufactured by its majority-owned subsidiary, https://www.otcmarkets.com/stock/KRTL/news/KRTL-Holding-Group-Highlights-Bolivian-Innovation-CaviGuard-Manufactured-by-SIGMA-as-Global-Model-in-Non-Invasive-Dental?id=498549
0 · Reply
NewsAndFilings
NewsAndFilings Oct. 31 at 12:09 PM
Yesterday's Recap: $BMTM TotallyKidz Chooses Bright Mountain Media as Exclusive SSP Partner $KRTL Congratulates SIGMA on National Recognition $GNIS Finalizes Metrospaces Agreement and Prepares Launch of First Platform
0 · Reply
MsGrumpy
MsGrumpy Oct. 30 at 3:41 PM
$KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia https://www.otcmarkets.com/stock/KRTL/news/KRTL-Holding-Group-Congratulates-SIGMA-on-National-Recognition-for-Pharmaceutical-Excellence-in-Bolivia?id=498009
0 · Reply